Purchase Order 75F40123P00413
Award Date 9/18/23
Potential Completion Date 9/21/25
Potential Value $95K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Loveland, CO 80537, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $126,772 firm fixed price purchase order to Bruker Biospin Corp. to deliver a solid-state NMR probe. The place of performance is in Billerica, Massachusetts, with work expected to be completed by April 2024. Per the solicitation, the FDA requested quotes for a solid-state NMR probe to add to an existing 500-MHz instrument in order to expand its analytical capabilities. As the leading regulatory agency for ensuring...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $732,711.84 firm fixed price purchase order to Bruker Biospin Corp. of Billerica, Massachusetts for an NMR CONSOLE AVANCE NEO 500 MHZ. The contract has a period of performance starting on September 18, 2022 through September 17, 2023 for the place of performance in Billerica, MA. Bruker Biospin Corp. will provide an NMR CONSOLE AVANCE NEO 500 MHZ as the prime contractor for the HHS FDA under this...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to Phoenix NMR LLC of Loveland, Colorado. The contract, valued at $172,837.00, is for the supply of an HXY NMR probe for a 750MHz spectrometer. The contract is not set aside for small businesses and is a sole-source award, indicating Phoenix NMR is the incumbent or preferred vendor for this...
- The U.S. Food and Drug Administration (FDA) awarded a $145,475.00 firm-fixed-price purchase order contract to Colonial Scientific, Inc., a small business, for the provision of a low-field benchtop Nuclear Magnetic Resonance (NMR) instrument. This specialized laboratory equipment will support the FDA's Human Foods Program in food safety screening and analytical applications, including the detection of per- and polyfluoroalkyl substances (PFAS) in food contact substances. The contract includes...
- The U.S. Food and Drug Administration awarded a $677,948.68 firm fixed price purchase order to Bruker Biospin Corp for a 400 MHz Nuclear Magnetic Resonance (NMR) spectrometer on September 29, 2021. The contract, which was completed by September 28, 2022, fulfills the FDA's Center for Drug Evaluation and Research requirement for high-resolution analytical equipment to characterize pharmaceutical ingredients, drug products, and excipients for stability and quality assessment in both liquid and...
- This federal contract award was issued by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for the procurement of a Quadruple Resonance Inverse (QCI) Detection Cryoprobe for high-field nuclear magnetic resonance (NMR) instrumentation. The contract, valued at $315,583.00, was awarded on a firm fixed-price basis without any set-aside designation. The award supports the FDA's 850 MHz Instrument Cryoprobe program, which focuses on advanced analytical...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the procurement of a 400MHz NMR spectrometer food screening system, under solicitation FDA-RFQ-CFSAN-2024-121654. The total ceiling value of the contract is $359,990.00, with a completion date of July 4, 2025. This award is not associated with a set-aside program. Bruker Biospin Corp is a manufacturer of scientific instruments and has a...
- This federal contract award to Nanalysis Corp is for the delivery of a benchtop nuclear magnetic resonance (NMR) spectrometer to the Food and Drug Administration (FDA), a civilian government agency. The $85,750 firm fixed price purchase order has a completion date of December 28, 2027. The award was derived from a recent solicitation for the NMR spectrometer, which did not have a set-aside designation. Nanalysis Corp, a Canadian manufacturer of NMR spectrometers and accessories, has previously...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, in the amount of $238,161.00. The contract is for the delivery of a cryogenically-cooled 13C direct detect probe and 3 years of preventative maintenance for an existing Bruker nuclear magnetic resonance (NMR) spectrometry system. There was no set-aside designation for this award. The original...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp a firm fixed price purchase order for $119,796.45 to provide preventive maintenance for an Advance III HD700 nuclear magnetic resonance spectrometer cryoprobe and CryoPlatform system AVHD700X located in Silver Spring, Maryland. The award has a period of performance through February 2025 and includes two optional one-year extension periods. This award responds to a sources sought notification...